Skip to main content
Y-Biologics, Inc logo

Y-Biologics, Inc — Investor Relations & Filings

Ticker · 338840 ISIN · KR7338840002 KO Professional, scientific and technical activities
Filings indexed 117 across all filing types
Latest filing 2023-12-13 Director's Dealing
Country KR South Korea
Listing KO 338840

About Y-Biologics, Inc

https://ybiologics.com/en/

Y-Biologics, Inc. is a biotechnology company specializing in the discovery and development of novel antibody-based therapeutics. The company's primary focus is on immuno-oncology, where it develops next-generation multispecific antibodies for the treatment of cancer. Y-Biologics leverages its proprietary human antibody discovery platform to advance its internal pipeline and support collaborations through technology transfers and joint development partnerships.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a standard regulatory requirement for insiders (directors/executives) to disclose their shareholdings and changes therein. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider transactions and ownership reports.
2023-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership and changes in holdings for a specific executive (Jang Myeong-ja) of Y-Biologics. This type of filing is a standard regulatory requirement for insider trading/ownership reporting, which corresponds to the 'Director's Dealing' category.
2023-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/KRX). This document details the acquisition of shares by an executive (Lee Sang-heon) of Y-Biologics. According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2023-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as an 'Insider Trading Report' or 'Director's Dealing') where company executives or major shareholders disclose changes in their shareholdings. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2023-12-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the share ownership of major shareholders (Park Young-woo and related parties) in Y-Biologics following a new listing. It is a formal disclosure of significant shareholding thresholds, which falls under the 'Major Shareholding Notification' category.
2023-12-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership and changes in holdings for a specific executive (Park Bum-chan) of Y-Biologics. This is a standard regulatory filing for insider trading or director/executive share ownership, which corresponds to the 'Director's Dealing' category.
2023-12-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.